IL37 and tuberculosis: A 2015 study indicated that prior to a six-month course of standard anti-TB drug therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol, ATB patients had significantly higher serum IL-37 levels and mRNA expression compared to post-treatment patients or healthy individuals (119).